March 1, 2019 Lab Top-10 PR/Corporate

Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering WASHINGTON, March 1, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that it has closed concurrent offerings of 12,100,000 shares of common stock at a price to the public of $123.00 per share and 1,650,000 shares of 4.75% Series A Mandatory Convertible Preferred... Read more

July 19, 2018 Lab Top-10 M&A, Partnerships

Danaher Announces Plan To Spin Off Dental Business Into An Independent, Publicly Traded Company

Danaher Announces Plan To Spin Off Dental Business Into An Independent, Publicly Traded Company WASHINGTON, July 19, 2018 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced its intention to spin off its Dental segment into an independent, publicly-traded company (“DentalCo”). The transaction is intended to be tax-free to Danaher shareholders and expected to be completed... Read more

July 12, 2018 Lab Top-10 PR/Corporate

SCIEX Supports Cancer Survival Research Through Donation to World Cancer Research Fund

By partnering with WCRF, SCIEX supports research that benefits cancer patients July 12, 2018 Framingham, MA — SCIEX, a global leader in life science analytical technologies, has donated US$17,500 (£12,613.21 GBP) to World Cancer Research Fund (WCRF). A donation of US$11,000 was made as the result of 98% participation in the annual SCIEX employee engagement survey, where SCIEX... Read more

March 9, 2018 Environ, Ag./Food & Bev Lab Top-10 M&A, Partnerships

Danaher to Acquire Integrated DNA Technologies

WASHINGTON, March 9, 2018 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) and Integrated DNA Technologies (“IDT”) announced today that Danaher has entered into a definitive agreement to acquire IDT, a privately-held provider of high-value consumables for genomics applications in molecular biology, qPCR, next generation sequencing, synthetic biology, gene editing and molecular diagnostics.  IDT’s primary... Read more

January 30, 2018 Lab Top-10 PR/Corporate

Danaher Announces Transition Plan For Chief Financial Officer

WASHINGTON, Jan. 30, 2018 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced that, effective January 1, 2019, Matthew R. McGrew, Group CFO of the Company’s Diagnostics and Dental platforms, will succeed Daniel L. Comas as Chief Financial Officer. Mr. Comas will continue as an Executive Vice President of the Company, and a member of the Office... Read more

November 28, 2017 Lab Top-10 Licensing, IP, and Legal PR/Corporate

Danaher Announces Leadership Appointment

WASHINGTON, Nov. 28, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its Board of Directors is appointing Joakim Weidemanis to the position of Executive Vice President of Danaher Corporation, with responsibility for the Company’s Product Identification and Water Quality platforms. With this appointment, Mr. Weidemanis will become an Executive Officer of the Company.... Read more

August 31, 2017 Atomic Spectroscopy Lab Top-10 M&A, Partnerships PR/Corporate

Danaher To Present At Vertical Research Partners Industrial Conference

WASHINGTON, Aug. 31, 2017 /PRNewswire/ — Danaher Corporation (NYSE:DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Vertical Research Partners Industrial Conference in Westbrook, Connecticut on Thursday, September 7, 2017 at 8:45 a.m. ET. About DanaherDanaher is a global science and technology innovator committed to helping... Read more

June 20, 2017 Lab Top-10 PR/Corporate

Danaher Announces Pricing Of Euro-Denominated Senior Notes Offering

WASHINGTON, June 20, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that its wholly-owned subsidiary, DH Europe Finance S.A. (“Danaher International”), has priced an offering of: €250 million principal amount of floating rate senior notes due 2022 at an offering price of 100.147% of the principal amount; and €600 million principal amount of... Read more